Article
Using Artificial Intelligence to Learn Optimal Regimen Plan for Alzheimer’s Disease
2023-01-29
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Alzheimer’s Disease (AD) is a progressive neurological disorder with no specific curative medications. While only a few medications are approved by FDA (i.e., donepezil, galantamine, rivastigmine, and memantine) to relieve symptoms (e.g., cognitive decline), sophisticated clinical skills are crucial to optimize the appropriate regimens given the multiple coexisting comorbiditi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 05881936-c0a7-5527-b3c6-1785969c450b
- DOI
- 10.1101/2023.01.26.23285064
